	Jie Zhang Registered Foreign Lawyer Beijing jie.zhang@davispolk.com +86 10 8567 5019 Ms. Zhang is an associate in Davis Polk’s Corporate Department, currently practicing as a Registered Foreign Lawyer in Beijing. Ms. Zhang’s practice focuses on advising corporate clients and private equity funds on M&A matters, including pre-IPO financings, buyouts, joint ventures, PIPEs, going private transactions and strategic investments. She also advises clients on securities law and general corporate matters.

Jie Zhang

Registered Foreign Lawyer

Beijing

Ms. Zhang is an associate in Davis Polk’s Corporate Department, currently practicing as a Registered Foreign Lawyer in Beijing. Ms. Zhang’s practice focuses on advising corporate clients and private equity funds on M&A matters, including pre-IPO financings, buyouts, joint ventures, PIPEs, going private transactions and strategic investments. She also advises clients on securities law and general corporate matters.

PROFESSIONAL EXPERIENCE
NEWS, INSIGHTS & EVENTS

Work Highlights

M&A

Tencent on its going-private offer to acquire Sogou
Tencent and Tencent Music Entertainment on the acquisition by a Tencent-led consortium of a 10% equity stake in Universal Music Group from Vivendi
Comcast Spectacor on its T1 esports joint venture with SK Telecom
Unitas Capital's sale of Jiahao Foods to Huabao International Holdings for approximately $694 million
iKang Healthcare on its acquisition by Yunfeng Capital and Alibaba
Tencent and Tencent Music Entertainment on their investments in Spotify, and on the cross-shareholding by Spotify in Tencent Music Entertainment
China Biologic Products on its acquisition of 80% equity interest in Tianxinfu for approximately $513 million
China Biologic Products redomiciles from Delaware to the Cayman Islands by its merging with and into its wholly owned subsidiary China Biologic Products
Tencent on its acquisition of China Music Corporation
Meituan Corporation on its strategic cooperation with DianPing
Special committee of Origin Agritech on its sale of commercial seed production and distribution business
China Biologic Products on its $590 million private placement
Sequoia on its various investments in pre-IPO companies, including Ke, Julive and Genesis Medtech
Megvii Technology on its pre-IPO financing
iQiyi on its $1.53 billion convertible notes financing
UCAR Technology on its $550 million Series B equity financing
IDG Capital Partners on its investment in SouFun

Capital Markets

Sinopec Group Overseas Development's $3 billion senior notes offering
Hong Yang Group's $125 million high-yield notes offering
Logan Property Holdings' $200 and $450 million senior notes offerings
Shandong Yuhuang Chemical's $300 million high-yield notes offering
China Aoyuan Property's $250 Million high-yield notes offering
Toyota Motor Credit Corporation's $750 million offering in Taiwan
Toyota Motor Credit Corporation's $1.75 billion offering

Credit

Lead arrangers in $8.5 billion financing to Coty and Galleria Co. for acquisition by Coty of P&G’s beauty business
Lead arrangers in $4 billion financing to Coty for acquisition of P&G’s beauty business
Lead arrangers in $4.5 billion financing in connection with the divesture of certain brands in P&G’s beauty business
Black Knight's $1.6 billion senior secured facilities

Professional History

Davis Polk since 2014

News

Practice Focus

Corporate

Bar Admissions

State of New York
Beijing Ministry of Justice - Registered

Education

B.S., Biological Sciences, Peking University, 2005
- with high honors
Ph.D., Cancer Biology, University of Chicago, 2011
J.D., Harvard Law School, 2014
- cum laude

Languages

Chinese
English

Browse Professionals